Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Pentahydrate Of Sodium Thiosulfate
2. Sodium Thiosulfate (usan)
3. Sodium Thiosulfate Anhydrous
4. Sodium Thiosulfate Pentahydrate
5. Thiosulfuric Acid, Disodium Salt
1. 7772-98-7
2. Sodiumthiosulfate
3. Disodium Thiosulfate
4. Hypo
5. Chlorine Control
6. Thiosulfuric Acid, Disodium Salt
7. Sodium Thiosulfate, Anhydrous
8. Disodium Sulfurothioate
9. Mfcd00003499
10. Na2s2o3
11. L0iyt1o31n
12. Thiosulfuric Acid (h2s2o3), Disodium Salt
13. Sodothiol
14. Sodium Sulfothioate
15. Sodothiol; Sulfactol; Sulfothiorine
16. Chlorine Cure
17. Declor-it
18. Hypo (van)
19. Hsdb 592
20. Einecs 231-867-5
21. Unii-l0iyt1o31n
22. Sodium Thiosulfate Concentrate
23. Ai3-01237
24. Sodium Thiosulfat
25. Sodium Thio-sulfate
26. Sodium Oxide Sulfide
27. Hypo Alcohol, In Ethanol
28. Anhydrous Sodium Thiosulfate
29. Ec 231-867-5
30. Disodium Thiosulphate
31. Sodium Thiosulfate (anhydrous)
32. Sodium Thiosulfate [mi]
33. Chembl3753202
34. Dtxsid9042417
35. Sodium Thiosulfate [hsdb]
36. Chebi:132112
37. Sodium Thiosulfate Solution, 1 M
38. Sodium Thiosulfate, Ar, >=98%
39. Sodium Thiosulfate, Lr, >=97%
40. Sodium Thiosulfate [who-dd]
41. Sodium Thiosulfate Solution, 0.1 M
42. Sodium Thiosulfate, P.a., 98.0%
43. Akos015856704
44. Akos016372312
45. Sodium Thiosulfate Solution, 0.01 M
46. Sodium Thiosulfate Solution, 0.025 M
47. Sodium Thiosulfate Anhydrous [ii]
48. Bp-21059
49. Sodium Thiosulfate, Reagentplus(r), 99%
50. Ft-0696570
51. O0522
52. Sodium Thiosulfate, 0.1n Volumetric Solution
53. D78333
54. Sodium Thiosulfate, 0.1n Standardized Solution
55. Sodium Thiosulfate, 1.0n Standardized Solution
56. Sodium Thiosulfate, 0.01n Standardized Solution
57. Sodium Thiosulfate, Saj First Grade, >=90.0%
58. Disodium;dioxido-oxo-sulfanylidene-lambda6-sulfane
59. Q339866
60. Sodium Thiosulfate, >=99.99% Trace Metals Basis
61. Sodium Thiosulfate, Vetec(tm) Reagent Grade, 99%
62. Thiosulfuric Acid (h2s2o3), Sodium Salt (1:2)
63. Sodium Thiosulfate Solution, 2 G/dl In Deionized Water
64. Sodium Thiosulfate, Anhydrous, Trace Metals Grade 99.99%
65. Sodium Thiosulfate, Purum P.a., Anhydrous, >=98.0% (rt)
66. Sodium Thiosulfate, Anhydrous, >=98% (calc. To The Dried Substance)
67. Sodium Thiosulfate, Acculute Standard Volumetric Solution, Final Concentration 0.1n
68. Sodium Thiosulfate 2.5m Solution (+/- 0.1m) Ph 7.0 - 9.0 (sodium Carbonate Added As A Preservative)
69. Sodium Thiosulfate Solution, Silver Stain Kit Component, 0.5 % (w/v) Sodium Thiosulfate In H2o
Molecular Weight | 158.11 g/mol |
---|---|
Molecular Formula | Na2O3S2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 0 |
Exact Mass | 157.90842477 g/mol |
Monoisotopic Mass | 157.90842477 g/mol |
Topological Polar Surface Area | 104 Ų |
Heavy Atom Count | 7 |
Formal Charge | 0 |
Complexity | 82.6 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Sodium thiosulfate |
PubMed Health | Sodium Thiosulfate (Intravenous) |
Drug Classes | Cyanide Antidote |
Drug Label | Sodium thiosulfate has the chemical name thiosulfuric acid, disodium salt, pentahydrate. The chemical formula is Na2S2O3 5H2O and the molecular weight is 248.17. The structural formula is:Structure of Sodium Thiosulfate PentahydrateSodium Thiosulf... |
Active Ingredient | Sodium thiosulfate |
Dosage Form | Solution |
Route | Intravenous |
Strength | 12.5gm/50ml (250mg/ml) |
Market Status | Prescription |
Company | Hope Pharms |
2 of 2 | |
---|---|
Drug Name | Sodium thiosulfate |
PubMed Health | Sodium Thiosulfate (Intravenous) |
Drug Classes | Cyanide Antidote |
Drug Label | Sodium thiosulfate has the chemical name thiosulfuric acid, disodium salt, pentahydrate. The chemical formula is Na2S2O3 5H2O and the molecular weight is 248.17. The structural formula is:Structure of Sodium Thiosulfate PentahydrateSodium Thiosulf... |
Active Ingredient | Sodium thiosulfate |
Dosage Form | Solution |
Route | Intravenous |
Strength | 12.5gm/50ml (250mg/ml) |
Market Status | Prescription |
Company | Hope Pharms |
Antidotes; Antitubercular Agents; Antioxidants; Chelating Agents
National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)
SODIUM THIOSULFATE, USP, IS INTENDED FOR PARENTERAL USE IN TREATMENT OF CYANIDE POISONING, BUT IT MAY BE APPLIED TO SKIN IN VARIOUS FORMS. CUTANEOUS INFECTIONS CAUSED BY STAPH AUREUS & STAPH EPIDERMIDIS MAY RESPOND TO CONCN AS LOW AS 0.5%. CONCN OF 2-8%...USED TO TREAT ACNE; THEY ARE ALSO ANTIFUNGAL.
Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 1005
/SODIUM THIOSULFATE USP/...IS USEFUL IN TOPICAL TREATMENT OF TINEA VERSICOLOR, TINEA CRURIS, & POSSIBLY MOST OTHER DERMATOPHYTOSES.
Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 1168
MEDICATION (VET): IN CYANIDE POISONING; HAS BEEN USED...EXTERNALLY IN RINGWORM, MANGE.
The Merck Index. 9th ed. Rahway, New Jersey: Merck & Co., Inc., 1976., p. 1122
For more Therapeutic Uses (Complete) data for SODIUM THIOSULFATE (6 total), please visit the HSDB record page.
PHYSICALLY INCOMPATIBLE WITH IV CALCIUM SALTS.
Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 548
3(?). 3= MODERATELY TOXIC: PROBABLE ORAL LETHAL DOSE (HUMAN) 0.5-5 G/KG, BETWEEN 1 OZ & 1 PINT (OR 1 LB) FOR 70 KG PERSON (150 LB).
Gosselin, R.E., H.C. Hodge, R.P. Smith, and M.N. Gleason. Clinical Toxicology of Commercial Products. 4th ed. Baltimore: Williams and Wilkins, 1976., p. II-86
Prevention of platinum-induced ototoxic hearing loss
Chelating Agents
Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)
Antidotes
Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
Antitubercular Agents
Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. (See all compounds classified as Antitubercular Agents.)
POORLY ABSORBED FROM BOWEL. ... THIOSULFATE ION DISTRIBUTES ITSELF IN EXTRACELLULAR FLUID.
Gosselin, R.E., H.C. Hodge, R.P. Smith, and M.N. Gleason. Clinical Toxicology of Commercial Products. 4th ed. Baltimore: Williams and Wilkins, 1976., p. II-86
/ANTIFUNGAL ACTION OF SODIUM THIOSULFATE, USP,/...IS PROBABLY ATTRIBUTABLE TO SLOW RELEASE OF COLLOIDAL SULFUR.
Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 1168
IN CYANIDE POISONING, SODIUM NITRITE IS INJECTED IV...TO PRODUCE METHEMOGLOBIN WHICH COMBINES WITH...CYANIDE ION & RENDERS IT TEMPORARILY INACTIVE IN FORM OF CYANMETHEMOGLOBIN. SODIUM THIOSULFATE /USP/ IS THEN INJECTED IV TO FORM NONTOXIC THIOCYANATE.
Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 779
THIOSULFATE SERVES AS SUBSTRATE FOR ENZYME RHODANESE, WHICH MEDIATES CONVERSION OF CYANIDE TO MUCH LESS TOXIC THIOCYANATE, WHICH IS EXCRETED IN URINE.
Casarett, L.J., and J. Doull. Toxicology: The Basic Science of Poisons. New York: MacMillan Publishing Co., 1975., p. 239
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35513
Submission : 2020-12-31
Status : Active
Type : II
NDC Package Code : 73435-013
Start Marketing Date : 2021-12-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-03-17
Pay. Date : 2022-02-07
DMF Number : 36782
Submission : 2022-02-15
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-11-18
Pay. Date : 2021-09-28
DMF Number : 36245
Submission : 2021-09-24
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3960
Submission : 1980-09-30
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20715
Submission : 2007-07-26
Status : Inactive
Type : II
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35513
Submission : 2020-12-31
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2021-11-18
Pay. Date : 2021-09-28
DMF Number : 36245
Submission : 2021-09-24
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3960
Submission : 1980-09-30
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-03-17
Pay. Date : 2022-02-07
DMF Number : 36782
Submission : 2022-02-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20715
Submission : 2007-07-26
Status : Inactive
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Glycerol Multi-Compendial
Application : Parenteral
Excipient Details : A & C's Glycerol multi-compendial is an excipient that meets USP-NF, EP and BP monographs.
Pharmacopoeia Ref : Multi-compendial
Technical Specs : Not Available
Ingredient(s) : Glycerol Excipient
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Application : Parenteral
Excipient Details : A & C's Glycerol is an excipient which meets the USP monograph.
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Potassium Chloride
Application : Parenteral
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Potassium Chloride Excipient
Dosage Form : Cream / Lotion / Ointment
Grade : Topical and Oral
Application : Topical
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?